Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Randomized, Controlled, Multicenter Clinical Trial to Demonstrate the Safety and Effectiveness of the NexSys® PCS Plasma Collection System With the Percent Plasma Nomogram (PPN) Feature

NCT04320823 is registered in ClinicalTrials.gov with Haemonetics Corporation as lead sponsor.

NCT NCT04320823
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04320823 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Randomized, Controlled, Multicenter Clinical Trial to Demonstrate the Safety and Effectiveness of the NexSys® PCS Plasma Collection System With the Percent Plasma Nomogram (PPN) Feature
Lead sponsor
Haemonetics Corporation
Phase
Not applicable
Overall status
Completed
Start date
January 6, 2020
Completion date
April 27, 2020
Enrollment
3,443 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

apheresis related hypotension